Recent investigations have focused on the convergence of GLP|GIP|GCGR activator therapies and DA communication. While GLP activators are increasingly employed for managing type 2 diabetes, their unexpected effects on motivation circuits, specifically governed by dopamine pathways, are gaining substantial interest. This paper details a concise as… Read More